|  | Cases (%) (n = 1229) | Controls (%) (n = 7374) | Crude OR (95 % CI) |
---|---|---|---|---|
Age (years) | <40 | 335 (27.3) | 2010 (27.3) | - |
 | 40–59 | 455 (37.0) | 2745 (37.2) | - |
 | 60–69 | 206 (16.8) | 1200 (16.3) | - |
 | 70–79 | 174 (14.2) | 1064 (14.4) | - |
 | ≥80 | 59 (4.8) | 355 (4.8) | - |
Sex | Male | 314 (25.6) | 1884 (25.6) | - |
 | Female | 915 (74.5) | 5490 (74.5) | - |
BMI | <25 | 435 (35.4) | 2717 (36.9) | 1.00 (referent) |
 | 25–29.9 | 337 (27.4) | 1977 (26.8) | 1.07 (0.92–1.26) |
 | 30–59.9 | 245 (19.9) | 1222 (16.6) | 1.27 (1.07–1.51) |
 | Unknown | 212 (17.3) | 1458 (19.8) | 0.85 (0.69–1.04) |
Smoking | Non-smoker | 693 (56.4) | 3603 (48.9) | 1.00 (referent) |
 | Current | 182 (14.8) | 1406 (19.1) | 0.66 (0.55–0.79) |
 | Past | 235 (19.1) | 1560 (21.2) | 0.78 (0.66–0.92) |
 | Unknown | 119 (9.7) | 805 (10.9) | 0.72 (0.55–0.92) |
Alcohol consumption | None | 244 (19.9) | 1233 (16.7) | 1.00 (referent) |
 | Current | 819 (66.6) | 4989 (67.7) | 0.81 (0.69–0.96) |
 | Past | 13 (1.1) | 74 (1.0) | 0.88 (0.48–1.62) |
 | Unknown | 153 (12.5) | 1078 (14.6) | 0.67 (0.52–0.85) |
Hypothyroidism | No | 1157 (94.1) | 7022 (95.2) | 1.00 (referent) |
 | Yes | 72 (5.9) | 352 (4.8) | 1.25 (0.96–1.63) |
Hyperthyroidism | No | 1195 (97.2) | 7284 (98.8) | 1.00 (referent) |
 | Yes | 34 (2.8) | 90 (1.2) | 2.29 (1.54–3.42) |
Goitera | No | 1129 (91.9) | 7313 (99.2) | 1.00 (referent) |
 | Yes | 100 (8.1) | 61 (0.8) | 10.60 (7.62–14.74) |
Diabetes mellitus | No | 1159 (94.3) | 7009 (95.1) | 1.00 (referent) |
 | Yes | 70 (5.7) | 365 (5.0) | 1.17 (0.89–1.54) |
 | DM durationb < 4 ys. | 24 (34.3) | 142 (33.9) | 1.00 (referent) |
 | DM durationb 4–8 ys. | 18 (25.7) | 133 (31.7) | 0.71 (0.32–1.60) |
 | DM durationb > 8 ys. | 28 (40.0) | 144 (34.4) | 1.22 (0.60–2.51) |
 | A1c <53 mmol/l (7 %) | 32 (45.7) | 175 (41.8) | 1.00 (referent) |
 | A1c ≥ 53 mmol/l (7 %) | 32 (45.7) | 217 (51.8) | 0.80 (0.46–1.38) |
 | Unknown A1c level | 6 (8.6) | 27 (6.4) | 1.24 (0.44–3.48) |
CHF | No | 1217 (99.0) | 7283 (98.8) | 1.00 (referent) |
 | Yes | 12 (1.0) | 91 (1.2) | 0.78 (0.42–1.45) |
IHD | No | 1160 (94.4) | 6934 (94.0) | 1.00 (referent) |
 | Yes | 69 (5.6) | 440 (6.0) | 0.93 (0.70–1.23) |
Hypertension | No | 968 (78.8) | 5918 (80.3) | 1.00 (referent) |
 | Yes | 261 (21.2) | 1456 (19.8) | 1.13 (0.95–1.34) |
Stroke/TIA | No | 1198 (97.5) | 7147 (96.9) | 1.00 (referent) |
 | Yes | 31 (2.5) | 227 (3.1) | 0.81 (0.55–1.19) |
Dyslipidemia | No | 1144 (93.1) | 6800 (92.2) | 1.00 (referent) |
 | Yes | 85 (6.9) | 574 (7.8) | 0.86 (0.67–1.11) |
NSAID | No prior use | 518 (42.2) | 3083 (41.8) | 1.00 (referent) |
 | 1–4 Rx. | 447 (36.4) | 2740 (37.2) | 0.97 (0.84–1.12) |
 | ≥5 Rx. | 264 (21.5) | 1551 (21.0) | 1.02 (0.85–1.21) |
ASA | No prior use | 1065 (86.7) | 6365 (86.3) | 1.00 (referent) |
 | 1–14 Rx. | 78 (6.4) | 481 (6.5) | 0.96 (0.75–1.25) |
 | ≥15 Rx. | 86 (7.0) | 528 (7.2) | 0.96 (0.74–1.26) |
Statins | No prior use | 1078 (87.7) | 6453 (87.5) | 1.00 (referent) |
 | 1–14 Rx. | 47 (3.8) | 337 (4.6) | 0.83 (0.60–1.15) |
 | ≥15 Rx. | 104 (8.5) | 584 (7.9) | 1.07 (0.83–1.38) |